These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38751258)

  • 1. Antimicrobial resistance pattern of Uro-Pathogens emphasizing non-lactose fermenting gram negative bacilli.
    Fatima A; Rizvi M; Sajjad M; Gohar H; Iffat W; Bushra R
    J Pak Med Assoc; 2024 Apr; 74(4):661-665. PubMed ID: 38751258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antibiotic resistance profiles of Gram negative bacilli associated with urinary tract infections (UTIs) in Karachi, Pakistan.
    Rasool MS; Siddiqui F; Ajaz M; Rasool SA
    Pak J Pharm Sci; 2019 Nov; 32(6):2617-2623. PubMed ID: 31969294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
    Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum Of Bacterial Culture And Drug Sensitivity Vs Resistance In Uncomplicated Urinary Tract Infection.
    Jadoon SA; Ahmed A; Irshad R
    J Ayub Med Coll Abbottabad; 2018; 30(3):432-438. PubMed ID: 30465381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report.
    Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS
    Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of drug-resistant bacterial isolates among pregnant women with UTI in maternity and children's hospital, Bisha, Saudi Arabia.
    Al-Shahrani GS; Belali TM
    Sci Rep; 2024 Mar; 14(1):7397. PubMed ID: 38548851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Purnapatre KP; Rao M; Pandya M; Khanna A; Chaira T; Bambal R; Upadhyay DJ; Masuda N
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ceftolozane/tazobactam against commonly encountered antimicrobial resistant Gram-negative bacteria in Lebanon.
    Araj GF; Berjawi DM; Musharrafieh U; El Beayni NK
    J Infect Dev Ctries; 2020 Jun; 14(6):559-564. PubMed ID: 32683345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
    Gomila A; Shaw E; Carratalà J; Leibovici L; Tebé C; Wiegand I; Vallejo-Torres L; Vigo JM; Morris S; Stoddart M; Grier S; Vank C; Cuperus N; Van den Heuvel L; Eliakim-Raz N; Vuong C; MacGowan A; Addy I; Pujol M;
    Antimicrob Resist Infect Control; 2018; 7():111. PubMed ID: 30220999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.
    Yang Q; Zhang H; Wang Y; Xu Z; Zhang G; Chen X; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Luo Y; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H; Badal RE
    BMC Infect Dis; 2017 Mar; 17(1):192. PubMed ID: 28264656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.
    Farrell DJ; Morrissey I; De Rubeis D; Robbins M; Felmingham D
    J Infect; 2003 Feb; 46(2):94-100. PubMed ID: 12634070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial resistance pattern for gram-negative uropathogens isolated from hospitalised patients and outpatients in Cartagena, 2005-2008].
    Castro-Orozco R; Barreto-Maya AC; Guzmán-Álvarez H; Ortega-Quiroz RJ; Benítez-Peña L
    Rev Salud Publica (Bogota); 2010 Dec; 12(6):1010-9. PubMed ID: 22030688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients].
    Wu ZY; Wu XS; Yao WY; Wang XF; Quan ZW; Gong W
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):24-31. PubMed ID: 33412630
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.
    Sader HS; Castanheira M; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2014; 58(3):1684-92. PubMed ID: 24379201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
    Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.